Bulletin board
Urgent Notice - Dr. Moolla Methadone Patients
Guidance for interim supply of methadone and buprenorphine/naloxone – Dr. H. Moolla more
Dr. Fern has Returned to Practice
As of May 23, 2019, Dr. Fern has returned to practice, resumed treating and prescribing Opioid Agonist Therapy for his patients more
Pharmacy Suspension Notice: Dewdney Drugs (1986) Ltd. – UPDATE
Resulting from the closure of Dewdney Drugs (1986) Ltd., it has become necessary for patients, NHIB clients, pharmacists more
Suspension - Dewdney Drugs (Regina)
Please be advised that SCPP has suspended the permit of Dewdney Drugs (1986) Ltd. until further notice as of 4:00 p.m. Thursday May 2, 2019, in accordance with The Pharmacy and Pharmacy Disciplines Act, SS 1996, c P-9.1 more
Communication to Members - Dr. Paul and Dr. R. Patel Methadone Patients
Saskatchewan will be the first province in Canada to be provided with an exemption 56 to provide more
AUTHUR WOO LICENCE SUSPENSION
Please be advised that SCPP has suspended the license to practice pharmacy for member Arthur Woo (D1971) until further notice, in accordance with The Pharmacy and Pharmacy Disciplines Act, SS 1996, c P-9.1 more
Membership Renewals Open
Our online renewal application process is now open and is available through your member portal; please access your home page to complete your renewal. All requirements for membership renewal need to be in the SCPP office by June 1, 2019.
Changes to Mifegymiso Ultrasound no longer required
Health Canada is informing Canadians that the prescribing and patient information for Mifegymiso has been updated more
SCOPe Newsletter March 2019
The SCOPe newsletter is one of the ways the College provides information to pharmacy professionals practising in Saskatchewan. Click here to download the most recent SCOPe newsletter.
Health Canada Drug Recall
Multiple Losartan-containing drugs voluntarily recalled because of potential for nitrosamine impurity
Health Canada is advising Canadians that multiple lots of Losartan-containing drugs are being voluntarily recalled by Teva Canada, Apotex Inc., Pharmascience Inc., and Pro Doc Limitée because of the potential for a nitrosamine impurity, N-Nitroso-N-methyl-4-aminobutyric acid (NMBA). NMBA is potentially a human carcinogen, which means that long-term exposure could increase the potential risk of cancer. more
Health Canada is advising Canadians that multiple lots of Losartan-containing drugs are being voluntarily recalled by Teva Canada, Apotex Inc., Pharmascience Inc., and Pro Doc Limitée because of the potential for a nitrosamine impurity, N-Nitroso-N-methyl-4-aminobutyric acid (NMBA). NMBA is potentially a human carcinogen, which means that long-term exposure could increase the potential risk of cancer. more
Eat Well Saskatchewan
Eat Well Saskatchewan is a free nutrition service offered by the College of Pharmacy and Nutrition more
2019 Wellspring Leadership Award
The Canadian Foundation for Pharmacy is pleased to announce the 2019 Wellspring Pharmacy Leadership Award Program more
Regulatory Bylaw Certificate - Methadone
Approval of the Registrar of the College of Physicians and Surgeons (CPSS) is not required when prescribing methadone for pain. There are also other exemptions more
TEMPORARY LICENCE SUSPENSION
Please be advised that SCPP has temporarily suspended the license to practice pharmacy for member Jennifer Yaholnistky (D4587) pending investigation of professional misconduct, in accordance with The Pharmacy and Pharmacy Disciplines Act, SS 1996, c P-9.1
Sask. Polytechnic SPTA Course
Saskatchewan Polytechnic is now accepting registrations for the Structured Practical Training and Assessment (SPTA) course Course listing
DRUG SHORTAGE - ELLA™
ella™ (ulipristal acetate) is an oral emergency contraceptive product. McKesson has identified a shortage until about December 7
New number to call for people seeking info about MAID
People seeking medically assisted death can now call the provincial 811 health line (CBC news)
OPIOID STICKERS AND PATIENT HANDOUT REQUIREMENTS
Mandatory Opioid Warning Sticker and Patient Information Handout
Health Canada announced "Regulations Amending the Food and Drug Regulations" on opioids that will alter the current opioid dispensing workflow of pharmacists more
Zhejiang Huahai Pharmaceuticals site non-compliant
Health Canada finds Zhejiang Huahai Pharmaceuticals site non-compliant with requirements for the manufacture of drug ingredients. No products are being recalled at this time more
EpiPen and EpiPen Jr Safety Alert
In a small number of cases, some EpiPen and EpiPen Jr auto-injector devices may not slide out of their carrier tub easily, or at all. Please check the devices prior to dispensing and return those that do not slide out of their case properly more
EpiPen® Shortage Update
Health Canada has issued an Interim Order allowing the importation of Auvi-Q® epinephrine auto-injectors from the United States for an initial period of two weeks to help mitigate the EpiPen® Shortage more.
CONTINUING PROFESSIONAL DEVELOPMENT FOR PHARMACY PROFESSIONALS (CPDPP)
Find CE Online Courses and Live Events: www.usask.ca/cpdpp
Regulatory Updates
EXEMPTION 56 - METHADONE
Saskatchewan will be the first province in Canada to be provided with an exemption 56 more..
EPIPEN® BACK ON SCHEDULE I
At the December meeting, Council decided not to extend the temporary bylaw that came into effect on August 27, 2018, which moved epinephrine ampoules from Schedule I to Schedule II for the treatment of anaphylaxis due to allergens. Therefore, effective December 31, 2018, epinephrine ampoules for anaphylaxis are no longer Schedule II and are back on Schedule I status...
Naloxone Unscheduled
Saskatchewan becomes the third province to move naloxone to unscheduled status more..
REGULATORY BYLAW REPEALED
Effective March 16, 2018, Part N, section 11(2) of the SCPP Regulatory Bylaws was repealed (linked document updated March 22) more..
MIFEGYMISO PRESCRIBING AND DISPENSING UPDATE
Please review the November 7, 2017, Health Canada updates to prescribing and dispensing information for Mifegymiso® here ..
CQI BYLAWS APPROVED
The Minister of Health has approved the bylaws that set the Continuous Quality Improvement (CQI) program requirement, which will be met by COMPASS starting with the 2017-2018 permit year. The new bylaws can be found in Section 12 of Part I in the SCPP Regulatory Bylaws. more ..
MINOXIDIL NOW UNSCHEDULED
Effective July 20, 2017, topical minoxidil, in concentrations of 5% or less, is now an unscheduled product and may be sold from any retail outlet (including online) more ..
Events
Sep
20
Building Recovery Capital in Canada Conference
September 20 in Regina. Recovery Capital Conference is now being held in 6 cities across Canada more